Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,165 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Sale · Disposed 2,641 · Balance 27,165 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.40. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.40. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 19, 2026 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,641 | $43.28 | $114,302.48 |
DisclosureSEC source: 0001104659-26-063812 · tm2615091-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,165 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.40. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 700 | $43.01 | $30,107.00 |
DisclosureSEC source: 0001104659-26-062498 · tm2614790-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,806 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.03. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 15,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019273 · tm267181-2_4seq1.xml · nonDerivative · entry 3 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,506 F3 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 735 | $59.53 | $43,754.55 |
DisclosureSEC source: 0001104659-26-019273 · tm267181-2_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,548 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019273 · tm267181-2_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,283 F1 · shares: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 587 | $59.76 | $35,079.12 |
DisclosureSEC source: 0001104659-26-017048 · tm266746-4_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,883 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 327 | $66.33 | $21,689.91 |
DisclosureSEC source: 0001104659-26-013522 · tm266005-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,470 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| January 09, 2026 Filed Jan 12, 2026 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 109 | $100.00 | $10,900.00 |
DisclosureSEC source: 0001104659-26-002864 · tm262949-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,797 F1 · balance_after: Includes 140 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated May 21, 2025. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,734 | $149.38 | $259,024.92 |
DisclosureSEC source: 0001104659-25-051603 · tm2515858-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,766 Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,287 | $185.60 | $424,467.20 |
DisclosureSEC source: 0001104659-25-020914 · tm258354-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,500 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 1,009 | $186.45 | $188,128.05 |
DisclosureSEC source: 0001104659-25-017091 · tm257622-3_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,787 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 3,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017091 · tm257622-3_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,796 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:42 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014857 · tm256927-2_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,500 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 11, 2025 Filed Feb 14, 2025 01:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 583 | $170.49 | $99,395.67 |
DisclosureSEC source: 0001104659-25-013139 · tm256634-1_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,424 Read SEC document |
| February 09, 2025 Filed Feb 14, 2025 01:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 315 | $182.15 | $57,377.25 |
DisclosureSEC source: 0001104659-25-013139 · tm256634-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,007 Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 58 | $215.00 | $12,470.00 |
DisclosureSEC source: 0001104659-25-002532 · tm252955-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,322 F1 · balance_after: Includes 32 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated November 5, 2024. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,901 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · derivative · entry 8 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,197 Underlying: Common Stock · 2,901 shares Expires 2029-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,802 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · derivative · entry 7 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,448 Underlying: Common Stock · 5,802 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 333 | $196.42 | $65,407.86 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · nonDerivative · entry 6 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,348 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.22 to $196.715. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,013 | $194.84 | $197,372.92 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · nonDerivative · entry 5 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,681 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.50 to $195.28. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,580 | $193.92 | $306,393.60 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · nonDerivative · entry 4 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,694 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.38 to $194.375. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,777 | $192.93 | $1,114,556.61 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · nonDerivative · entry 3 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,274 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.35 to $193.34. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 2,901 | $42.15 | $122,277.15 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,802 | $71.00 | $411,942.00 |
DisclosureSEC source: 0001104659-24-114302 · tm2427544-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2024 Filed Sep 11, 2024 21:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 31 | $215.00 | $6,665.00 |
DisclosureSEC source: 0001104659-24-098965 · tm2423831-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,348 Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-24-092426 · tm2422550-1_4seq1.xml · derivative · entry 4 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,250 Underlying: Common Stock · 5,000 shares Expires 2029-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,799 | $190.04 | $721,961.96 |
DisclosureSEC source: 0001104659-24-092426 · tm2422550-1_4seq1.xml · nonDerivative · entry 3 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,379 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.51 to $190.37. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,201 | $189.16 | $227,181.16 |
DisclosureSEC source: 0001104659-24-092426 · tm2422550-1_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,178 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.51 to $189.35. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,000 | $71.00 | $355,000.00 |
DisclosureSEC source: 0001104659-24-092426 · tm2422550-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 109 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated March 26, 2024. Read SEC document |
| March 22, 2024 Filed Mar 27, 2024 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $195.22 | $97,610.00 |
DisclosureSEC source: 0001104659-24-039199 · tm249882-1_4seq1.xml · nonDerivative · entry 3 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,270 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.21 to $195.23. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 22, 2024 Filed Mar 27, 2024 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 3,062 | $194.46 | $595,436.52 |
DisclosureSEC source: 0001104659-24-039199 · tm249882-1_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,770 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.225 to $194.985. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 22, 2024 Filed Mar 27, 2024 00:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 825 | $193.70 | $159,802.50 |
DisclosureSEC source: 0001104659-24-039199 · tm249882-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,832 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.19 to $194.00. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,255 | $179.26 | $404,231.30 |
DisclosureSEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 4 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,657 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.17 to $180.14. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 52 | $179.98 | $9,358.96 |
DisclosureSEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 3 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,912 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.11 to $180.01. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 80 | $179.98 | $14,398.40 |
DisclosureSEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,964 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.11 to $180.01. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 6,218 | $179.23 | $1,114,452.14 |
DisclosureSEC source: 0001104659-24-030588 · tm247936-1_4.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,044 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.17 to $180.25. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-24-024892 · tm246514-1_4seq1.xml · derivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 8,000 | $2.07 | $16,560.00 |
DisclosureSEC source: 0001104659-24-024892 · tm246514-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,376 | $0.00 Strike: $194.87 | $0.00 |
DisclosureSEC source: 0001104659-24-022575 · tm245999-7_4seq1.xml · derivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,376 Underlying: Common Stock · 4,376 shares Expires 2034-02-09 F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and becomeexercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-022575 · tm245999-7_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,262 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents acontingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · balance_after: Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan onDecember 31, 2023. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:24 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,387 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-23-031312 · tm239130-4_4seq1.xml · derivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 4,387 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:24 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 4,387 | $2.07 | $9,081.09 |
DisclosureSEC source: 0001104659-23-031312 · tm239130-4_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022083 · tm236006-8_4seq1.xml · derivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,560 | $270.00 | $421,200.00 |
DisclosureSEC source: 0001104659-23-014611 · tm236006-1_4seq1.xml · nonDerivative · entry 6 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,091 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 940 | $265.00 | $249,100.00 |
DisclosureSEC source: 0001104659-23-014611 · tm236006-1_4seq1.xml · nonDerivative · entry 5 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 361 | $251.72 | $90,870.92 |
DisclosureSEC source: 0001104659-23-014611 · tm236006-1_4seq1.xml · nonDerivative · entry 4 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,591 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.42 to $252.06, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 949 | $250.73 | $237,942.77 |
DisclosureSEC source: 0001104659-23-014611 · tm236006-1_4seq1.xml · nonDerivative · entry 3 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,952 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.42 to $251.34, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,700 | $249.91 | $424,847.00 |
DisclosureSEC source: 0001104659-23-014611 · tm236006-1_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,901 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.41 to $250.40, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 490 | $249.08 | $122,049.20 |
DisclosureSEC source: 0001104659-23-014611 · tm236006-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,601 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.34 to $249.28, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 10, 2023 02:20 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,170 | $256.00 | $299,520.00 |
DisclosureSEC source: 0001104659-23-002388 · tm232886-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,091 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 31 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.